A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most ...
A highly sensitive blood test can detect signs of pancreatic cancer that standard methods often miss, according to results of ...
A single preoperative blood sample may help improve the prediction of recurrence or metastasis in patients with colorectal ...
A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most ...
Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer missed by standard testing, potentially helping physicians identify ...
Hosted on MSN
Pancreatic cancer breakthrough as doctors develop new blood test that can pick up 'residue cells'
Patients who have been treated for pancreatic cancer could benefit from a newly developed blood test that could identify tiny traces of the disease often missed by scans. The highly sensitive test has ...
Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, ...
Balancing Rigor and Urgency: The Development of Trastuzumab Deruxtecan in Rare and Ultra-Rare Sarcomas Cancer genetic counseling and testing have become integral to medicine given expanding knowledge ...
Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of ...
Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results